In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.
Using the RAW117 lymphoma/lymphosarcoma system syngeneic to Balb/c strain mice, variant sublines have been selected for enhanced blood-borne liver colonization in vivo or for lack of binding to immobilized lectins in vitro. The kinetic organ distributions of intravenously injected, 3H-thymidine-labelled RAW117 parental cells and a subline sequentially selected ten times for enhanced liver colonization were similar, suggesting that the differences in malignancy between these two cell lines were not due to dramatic differences in organ localization properties. Examination of the malignant properties of the selected sublines and cell clones derived from these in immune-impaired animals indicated that host immune status was important in determining the quantity of experimental metastases in this system. Although impairment of T-cell or NK-mediated anti-tumor responses by using 400 R 60Co-irradiated or Balb/c nude (nu/nu) mice suggested that certain immunologic responses were not effective in preventing experimental metastasis, impairment of macrophage function with chlorine, silica, trypan blue, carrageenan, cyclophosphamide or pristane were effective and resulted in enhanced malignancy of the parental RAW117 line. In contrast, impairment of macrophage function had little or no effect on the experimental metastatic properties of highly malignant RAW117 sublines or clones. In vitro humoral responses or cell-mediated immunologic assays using lymphoid cells from normal or tumor-bearing hosts failed to demonstrate antibody-mediated or antibody-dependent cell-mediated cytotoxicity (ADCC), T-cell or NK-cell responses against RAW117 cells. However, poly I: C activated macrophages were more effective against parental RAW117 cells than against a highly metastatic subline in cytolysis and cytostasis assays suggesting that the highly metastatic RAW117 cells can more readily escape macrophage-mediated host defenses.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000920:Antibody-Dependent Cell Cytotoxicity; D002455:Cell Division; D002460:Cell Line; D005260:Female; D007109:Immunity; D066298:In Vitro Techniques; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary; D008223:Lymphoma / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology / Q000532:radiotherapy / Q000556:secondary; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology / Q000532:radiotherapy / Q000556:secondary; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D014410:Tumor Stem Cell Assay
D000912:Antibodies, Neoplasm